Your browser doesn't support javascript.
loading
Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study.
Cui, Lei; Wang, Chan-Juan; Lian, Hong-Yun; Zhang, Li; Ma, Hong-Hao; Wang, Dong; Chen, Fen-Fen; Zhang, Qing; Yang, Ying; Wei, Ang; Huang, Xiao-Tong; Zhu, Ting; Wang, Tian-You; Li, Zhi-Gang; Zhang, Rui.
Afiliación
  • Cui L; Hematologic Diseases Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Wang CJ; Beijing Key Laboratory of Pediatric Hematology-Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Lian HY; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.
  • Zhang L; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China.
  • Ma HH; Beijing Key Laboratory of Pediatric Hematology-Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Wang D; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.
  • Chen FF; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China.
  • Zhang Q; Hematology Center, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
  • Yang Y; Beijing Key Laboratory of Pediatric Hematology-Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Wei A; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.
  • Huang XT; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China.
  • Zhu T; Hematology Center, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
  • Wang TY; Beijing Key Laboratory of Pediatric Hematology-Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Li ZG; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.
  • Zhang R; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China.
Am J Hematol ; 98(4): 598-607, 2023 04.
Article en En | MEDLINE | ID: mdl-36594188
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Histiocitosis de Células de Langerhans / Cladribina Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Humans Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Histiocitosis de Células de Langerhans / Cladribina Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Humans Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article País de afiliación: China